The effect of metformin on glucose homeostasis during moderate exercise

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Merethe Hansen, Marie K. Palsøe, Jørn Wulff Helge, Flemming Dela

OBJECTIVE: We investigated the role of metformin on glucose kinetics during moderate exercise.

RESEARCH DESIGN AND METHODS: Before, during, and after a 45-min bout of exercise at 60% VO2max, glucose kinetics were determined by isotope tracer technique in patients with type 2 diabetes mellitus with metformin treatment (DM2+Met) or without metformin treatment (DM2) and in healthy control subjects (CON) matched for BMI and age. Glucoregulatory hormones and metabolites were measured throughout the study.

RESULTS: Plasma glucose concentration was unchanged during exercise in CON but decreased in DM2. No significant change was found in DM2+Met. Hormones and metabolites showed no differences among the groups except for elevated exercise-induced concentrations of lactate in DM2 (area under the curve [AUC] 31 ± 1% vs. CON) and glucagon in DM2 (AUC 5 ± 1% vs. DM2+Met). Free fatty acid levels were lower in DM2+Met than in DM2 (AUC -14 ± 1%). Absolute values of the baseline glucose rate of appearance (Ra) were elevated in DM2 and DM2+Met, but the increase in glucose Ra relative to baseline was blunted in DM2 (19 ± 1%) and DM2+Met (18 ± 4%) compared with CON (46 ± 4%). Glucose rate of disappearance relative to baseline increased more in CON (31 ± 3%) than in DM2 (6 ± 1%) and DM2+Met (21 ± 2%), showing a small increase caused by metformin. Glucose metabolic clearance rate relative to baseline was similar during exercise in DM2 (33 ± 1%) and CON (35 ± 3%) but was improved in DM2+Met (37 ± 3%) compared with DM2.

CONCLUSIONS: Metformin has a positive effect on glucose homeostasis during exercise.

OriginalsprogEngelsk
TidsskriftDiabetes Care
Vol/bind38
Udgave nummer2
Sider (fra-til)293-301
Antal sider9
ISSN0149-5992
DOI
StatusUdgivet - feb. 2015

ID: 132011203